Can You Lose an Allergy? The Science of Resolution

Allergies can and do resolve on their own, particularly in children. Roughly half of children with cow’s milk allergy outgrow it by around age nine, and egg allergy resolves even earlier for many kids. But the likelihood of losing an allergy depends heavily on which allergen is involved, how the immune system was sensitized in the first place, and whether the person is a child or an adult. The biology behind allergy resolution turns out to be an active process, not simply forgetting, and understanding it has opened the door to treatments designed to push the immune system toward tolerance.

Which Allergies Are Most Likely to Disappear

Not all allergies carry the same odds of resolution. The classic “outgrowable” food allergies are cow’s milk, egg, wheat, and soy. In a large food allergy cohort, milk allergy resolved in about 35% of children, soy in 32%, and wheat in 27%.¹ The timeline varies: half of children with cow’s milk allergy reached tolerance at a median age of about 8.7 years, while egg allergy hit the 50% resolution mark closer to age 5.6.² These are medians, meaning some children resolve earlier and some considerably later.

Peanut, tree nut, and shellfish allergies tell a different story. In the same cohort, peanut allergy resolved in only about 3.8% of children, and shellfish allergy in just 3.5%.¹ This pattern holds broadly across studies: cow’s milk, egg, and wheat have a more favorable prognosis, while peanut, tree nut, and seafood allergies tend to persist.³ If you have been allergic to shrimp since childhood, the odds that time alone will fix it are not in your favor.

Why the difference? Part of the answer is structural. The proteins in milk and egg that trigger immune reactions are more heat-sensitive and more easily broken down by digestion, which may give the immune system more opportunities to encounter partially degraded versions and learn to tolerate them. Peanut allergens, by contrast, are stubbornly stable proteins that survive cooking, digestion, and processing largely intact, making it harder for the body to reclassify them as harmless.

What Actually Happens When an Allergy Fades

Losing an allergy is not passive. It involves measurable immunological shifts, and the best-studied of these involves a class of immune cells called regulatory T cells. These cells are concentrated in the gut lining and airways, right where your body encounters food proteins and inhaled particles. Their job is to dampen immune responses that are misdirected or disproportionate. They do this by releasing anti-inflammatory signaling molecules that suppress the activation of the immune cells responsible for allergic reactions.⁴

In allergic individuals, this regulatory machinery is either overwhelmed or insufficient. When tolerance develops, whether naturally or through treatment, regulatory T cells ramp up and start to shift the immune system’s response away from alarm and toward calm. The result is a gradual suppression of the cells that drive allergic inflammation.

Alongside this cellular shift, the antibody landscape changes. In an active allergy, the immune system produces IgE antibodies targeted at the allergen, and those antibodies are the trigger for symptoms like hives, swelling, and anaphylaxis. As tolerance develops, the body increasingly produces a different antibody called IgG4 instead. IgG4 acts as a competitive blocker: it binds to the allergen before IgE can, preventing the chain reaction that causes symptoms.⁵ In children who are sensitized to peanut but tolerate it clinically, IgG4 antibodies can directly block peanut proteins from activating mast cells, the cells that release histamine and cause acute allergic symptoms.⁶

So allergy resolution is really a two-pronged process: the immune system learns to suppress its attack (via regulatory T cells) and simultaneously builds a molecular shield (via IgG4) that intercepts allergens before they can trigger trouble.

Can Adults Lose Allergies Too

Most of the research on natural allergy resolution focuses on children, but adults are not entirely locked in. Hay fever is a useful example. A long-term follow-up of patients diagnosed with hay fever or allergic asthma found that among those tracked over decades, about 70% no longer suffered severe symptoms. People who had spontaneously recovered from hay fever showed lower levels of both IgE and IgG antibodies to grass pollen compared with people who still had active symptoms.⁷ The antibody decline tracked with the symptom improvement, suggesting that the same tolerance mechanisms seen in childhood food allergies can operate in adults with respiratory allergies, just more slowly.

Drug allergies are another area where waning is common but underrecognized. Penicillin allergy is reported by somewhere between 8% and 25% of populations studied globally, making it one of the most common allergy labels in medical records. Yet most of those diagnoses were made in childhood and relate to events that were either not truly allergic in nature or represent genuine allergies that have since faded.⁸ Studies using formal skin testing and drug challenges consistently find that the vast majority of people labeled penicillin-allergic can safely take the drug. The practical problem is that few people are ever retested, so they carry the label, and their medical care is shaped by it, for life.

Adult-onset food allergies, on the other hand, appear to be stickier. Shellfish allergy, for instance, often develops in adulthood, and once established, it rarely resolves on its own. Shellfish allergy prevalence is estimated at up to 3% in the adult population, making it one of the most common food allergies in adults.⁵ The mechanisms behind adult-onset persistence are less well understood, but the immune system in adulthood may have fewer opportunities and less plasticity to retrain itself compared with the rapidly maturing immune systems of young children.

Speeding Up Resolution With Dietary Exposure

One of the more practical findings in allergy research is that certain forms of exposure can accelerate the path to tolerance. For milk and egg allergies, the key insight involves baking. Many children who react to a glass of milk or a scrambled egg can safely eat milk and egg in baked goods like muffins and cakes. The high temperatures of baking alter the allergenic proteins enough to reduce their ability to trigger reactions, and regular consumption of baked forms appears to help children outgrow their allergies faster than strict avoidance alone.⁹ This approach is now widely used in clinical practice for milk- and egg-allergic children, broadening their diets and improving quality of life while the immune system gradually adjusts.

The theoretical basis for why early oral exposure promotes tolerance rather than allergy connects to what researchers call the dual allergen exposure hypothesis. The idea is that eating a food introduces it to the gut immune system, which is naturally geared toward tolerance. But encountering that same food protein through inflamed or broken skin, as can happen in infants with eczema, tends to prime the immune system for an allergic response instead.¹⁰ This has reshaped infant feeding guidelines: decades of advising parents to delay introduction of allergenic foods has given way to recommendations for early introduction, particularly for high-risk infants.

What Immunotherapy Can and Cannot Do

For allergies that do not resolve on their own, particularly peanut allergy, immunotherapy offers a way to push the immune system toward tolerance from the outside. Oral immunotherapy involves giving gradually increasing doses of the allergen under medical supervision until the patient can consume a maintenance dose without reacting. The immune shifts it produces mirror those seen in natural resolution: regulatory T cells increase, allergen-specific IgE eventually declines, and IgG4 rises to block allergic activation.¹¹

The big question is whether immunotherapy creates lasting tolerance or just temporary desensitization. Desensitization means you can tolerate the food while you keep eating it regularly, but if you stop, the protection fades. Sustained unresponsiveness means you can stop treatment and still tolerate the food. In one peanut oral immunotherapy trial, about half of the patients who completed the protocol could tolerate a large peanut dose four weeks after stopping treatment, meeting the threshold for sustained unresponsiveness.¹² The patients who achieved sustained tolerance had higher levels of IgG4 neutralizing antibodies that could disrupt allergen-IgE interactions, suggesting that IgG4 may be a useful biomarker for predicting who will maintain tolerance after treatment ends.¹³

Immunotherapy is not risk-free. Allergic reactions during treatment, including serious ones, are a well-documented side effect. And the distinction between desensitization and true tolerance means that even after successful treatment, many patients need to continue eating the allergen regularly to maintain protection. For a family managing a severe peanut allergy, this changes the calculation from “never eat it” to “eat it regularly and carefully,” which is a meaningful improvement but not quite the same as losing the allergy entirely.

How Doctors Confirm That an Allergy Is Gone

Blood tests and skin prick tests can suggest that tolerance is developing, but they are not definitive. IgE levels to a given food can remain detectable even after clinical tolerance has been established. The gold standard for confirming that an allergy has truly resolved is an oral food challenge: the patient eats the food in gradually increasing amounts under medical supervision, and if no reaction occurs, the allergy is considered resolved.¹⁴

Newer diagnostic approaches are trying to refine predictions so that fewer challenges are needed. One approach uses patterns of IgE antibodies directed at specific parts of the allergen protein, rather than the allergen as a whole. An algorithm combining these epitope-specific IgE measurements with standard peanut IgE levels predicted allergy status with an accuracy of about 84-87% in young children.¹⁵ Better prediction could spare children unnecessary food challenges while also catching cases where an allergy has resolved and the child is still needlessly avoiding a food.

Non-IgE-mediated food allergies, like food protein-induced enterocolitis syndrome (FPIES), present a different diagnostic challenge. Because FPIES does not involve IgE antibodies, standard allergy blood tests and skin prick tests are not helpful. Many children outgrow FPIES by age three or four, but confirming this requires a supervised oral food challenge, the same endpoint as for IgE-mediated allergies.¹⁶

When the Allergy Is Gone but the Fear Remains

Here is where the science bumps into human psychology. Even after a food challenge demonstrates that a child can safely eat a food, a substantial number of families never reintroduce it. One study found that a quarter of previously allergic patients continued their avoidance diet despite a negative food challenge.¹⁷ Among the reasons: fear of a reaction, doubt about whether the allergy was truly gone, conflicting advice from other doctors, and the child simply not wanting to eat the food.

In another cohort, about 8% of families never even gave the cleared food to their child at all. Parents cited fear of adverse reactions as the most common reason.¹⁸ After years of hypervigilance around a life-threatening allergy, telling a parent “it’s fine now, go ahead and feed them peanut butter” can feel terrifying regardless of what the test showed. This is a real clinical problem, not just an emotional footnote. A child who has been told they are allergic to milk for their entire life may internalize that identity, and both the child and the family may need structured support to transition to eating the food normally.

Allergists increasingly recognize that the challenge result is not the end of care. Families often benefit from a gradual reintroduction plan, ideally with follow-up appointments, to build confidence that the tolerance is real and stable.

The Gut Microbiome and the Epigenetic Layer

The composition of the gut microbiome appears to influence whether allergies develop and whether they resolve. Bacteria in the gut produce short-chain fatty acids through the fermentation of dietary fiber, and there is growing evidence that these fatty acids, particularly acetate, propionate, and butyrate, have a protective effect against allergic diseases in early childhood, including eczema, asthma, and IgE-mediated food allergy.¹⁹ The proposed mechanism is that these fatty acids help train the immune system toward tolerance by supporting the development and function of regulatory T cells in the gut.

Epigenetic modifications add another layer. These are chemical changes to DNA packaging that turn genes on or off without altering the DNA sequence itself. Research has shown that epigenetic changes in genes related to immune regulation can influence whether someone develops sustained tolerance during immunotherapy or reverts to reactivity once treatment stops.²⁰ In other words, the durability of allergy resolution may depend not just on which antibodies the immune system makes right now, but on whether the underlying gene expression patterns have been stably reprogrammed. This is still an active area of research, but it offers a potential explanation for why some people lose their allergies permanently while others seem to hover at the edge of tolerance, vulnerable to relapse under stress or illness.

The interplay between gut bacteria, epigenetic changes, and immune cell behavior also helps explain why allergy resolution is not a single switch but more like a dial that can move in either direction. Factors like antibiotic use, dietary changes, infections, and stress can all shift the balance. A child who appeared to have outgrown a milk allergy might, in rare cases, experience a recurrence after a severe illness that disrupts gut microbial communities and immune regulation. The biology of tolerance, in short, is more dynamic and more fragile than most people assume.